News Headlines

  1. Sterling Invests £6M In Pilot Plant Facility

    Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions is investing £6M into its pilot plant facility at its UK site to enhance its scale-up and small to midscale commercial API manufacturing capabilities.

  2. FDA Issues Final Guidance To Advance Policies For Drug Development Process

    This guidance provides information on the procedures and general policies adopted by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) for special protocol assessment (SPA).

  3. Phoenix Molecular Designs Announces Manufacturing Collaboration With WuXi STA To Advance PMD-026 Toward IND

    Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026 needed for IND-enabling toxicology studies and a Phase I study in women.

  4. Advent International Enters Into Exclusive Negotiations To Acquire Zentiva, Sanofi’s European Generics Business

    Advent International (“Advent”) and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,9B[1]. Advent’s offer is firm, binding and fully financed.

  5. Cambrex Invests In New Continuous Flow Technology At Its High Point, NC Facility

    Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has completed the installation of multiple continuous flow reactor platforms at its High Point, NC facility.

  6. Mayne Pharma Launches Amiodarone Tablets 200mg In The United States

    Mayne Pharma Group Limited is pleased to announce the launch of amiodarone tablets, 200mg, in the United States.

  7. Shire Announces Sale Of Oncology Business To Servier For $2.4B

    Shire plc the leading global biotechnology company focused on rare diseases announces recently that it has entered into a definitive agreement with Servier S.A.S. (“Servier”) to sell its Oncology business for $2.4B.

  8. MilliporeSigma Helps Accelerate Global Access To Affordable Vaccines

    MilliporeSigma recently announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.

  9. Catalent Completes $5.5M Expansion Of Clinical Storage At Philadelphia Facility

    Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced it has completed a $5.5M expansion program at its 200,000+ square foot Philadelphia, Pennsylvania, site to provide additional clinical packaging and storage capacity.

  10. Outsourced Pharma Boston 2018 Agenda Update -- Mersana Therapeutics named Spotlight Leadership Company --

    April 11, 2018, Erie, PA: Outsourced Pharma Boston will feature Mersana Therapeutics as its Spotlight Leadership Company at its conference for professionals of biotech, pharma, and contract development and manufacturing organizations May 14-15, 2018 at the State Room in downtown Boston.